Tanya: Tell us about your background and what led you to animal health innovation.
Jamie: My career has focused on advancing precision molecular technologies, particularly in genomics and targeted protein analysis. I’ve spent more than two decades working at the intersection of science, translational research, and commercial execution — helping bring high-specificity molecular platforms from development into real-world application.
While much of my early work was in human health, particularly oncology and precision medicine, the scientific principles are universal: biology is complex, and measurement matters. The opportunity in animal health is enormous. Livestock systems are increasingly data-driven, yet molecular insights at the protein level remain underutilized. Bringing precision proteomic tools into agricultural settings felt like a natural extension of the work I’ve done throughout my career.
Animal health deserves the same rigor and technological advancement we expect in human medicine.
Tanya: What problem is Pictor trying to solve?
Jamie: At its core, Pictor is addressing a measurement gap.
Many existing animal health assays rely on single-analyte detection or simplified immune targets. But biological systems — particularly immune responses — are not simple. They are dynamic, heterogeneous, and influenced by numerous variables.
We believe a multi-analyte, targeted proteomic approach can provide a more nuanced understanding of immune response patterns in livestock. Rather than asking whether a single biomarker is present or absent, we can evaluate broader antigen response profiles and generate more informative data.
Our focus is on enabling better insight — not just more testing.
Tanya: What makes targeted proteomics particularly powerful in animal health?
Jamie: Targeted proteomics allows simultaneous measurement of multiple defined protein targets with high specificity. That multiplex capability matters in infectious disease, immune response characterization, and herd-level monitoring.
In livestock systems, scale and practicality are critical. Any technology must be operationally feasible, cost-conscious, and adaptable to real-world workflows such as milk sampling or serum collection.
By designing assays that balance analytical depth with field practicality, we believe proteomics can become a foundational tool in next-generation herd management.
Importantly, this isn’t about replacing existing tools overnight — it’s about expanding the molecular resolution available to producers, veterinarians, and researchers.
Tanya: How do you see animal health evolving over the next 5–10 years?
Jamie: Animal health is moving toward greater integration of data, biology, and systems thinking.
We’re seeing growth in:
- Precision nutrition
- Biologic-based interventions
- Microbiome research
- Digital herd management
- Sustainable livestock practices
But molecular analytics must keep pace.
Over the next decade, I expect we’ll see broader adoption of multi-analyte testing platforms that provide more detailed immune and health profiling — similar to the evolution we’ve seen in human precision medicine.
The producers and companies that thrive will be those who can translate biological complexity into actionable, operational insight.
Tanya: What is your broader vision for Pictor?
Jamie: Our vision is to build a scalable, targeted proteomic platform that bridges research and real-world application — across both livestock and human health.
We are focused on:
- Expanding antigen panels thoughtfully
- Generating rigorous validation data
- Collaborating with academic and industry partners
- Ensuring our tools are usable in field settings
Long term, we believe protein-level analytics will become as fundamental to animal health decision-making as genomic testing has become in human medicine.
We are at the early stages of that shift.
Tanya: What advice would you give emerging innovators in animal health?
Jamie: Start with biology, not hype.
Animal health is a complex ecosystem that involves producers, veterinarians, regulators, researchers, and global supply chains. Technologies must be scientifically robust, economically viable, and operationally realistic.
It’s not enough to build something technically elegant — it must function within the daily constraints of livestock systems.
At the same time, we shouldn’t underestimate how ready the industry is for meaningful innovation. There is strong demand for tools that improve resilience, sustainability, and productivity — especially as global pressures on food systems continue to increase.
About Jamie Platt
Jamie is CEO of Pictor Diagnostics with 20 years of proven leadership in genomics and molecular diagnostics. She has guided teams in developing and commercializing 40+ high-complexity tests (LDTs and IVDs) globally. As COO at PGDx (acquired by LabCorp) and Inivata (acquired by NeoGenomics), she led the launch of liquid biopsy products, and two M&A exits totaling ~$1B in 2021.
